Immunotherapy and new treatments
- 4 October 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 24 (6) , 520-528
Abstract
Purpose of review: This review comes at a time where new techniques in immunotherapy administration are being developed, new innovations are being incorporated to standard techniques, and new regulations are being adopted regarding the creation and storage of allergen extracts. Prior to the release of updated practice parameters regarding allergic rhinitis and immunotherapies, this review article provides a synopsis of current recommendations, a comparison of the practices in the United States and those of Europe, and an examination of experimental methods that are being studied. Recent findings: This article seeks to review and discuss the various methods of administration, build up schedules, efficacy, effect on other atopic symptoms, and safety associated with allergen immunotherapy. Summary: Innovations in standard techniques, such as new allergoids for SCIT, appear to be effective in improving symptoms and increasing IgG levels for grass allergens. Data for newer techniques is less clear. There appears to be increased treatment-related adverse events for ILIT, worse symptom scores compared with placebo for IDIT, and insufficient studies regarding the effectiveness of EPIT for aeroallergens. New regulations seek to standardize the documentation, storage, and creation of allergen extracts.Keywords
This publication has 69 references indexed in Scilit:
- Systematic review of real‐world persistence and adherence in subcutaneous allergen immunotherapyInternational Forum of Allergy & Rhinology, 2022
- Effectiveness and safety of a microcrystalline tyrosine‐adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real‐life prospective observational studyImmunity, Inflammation and Disease, 2022
- Adherence to allergen immunotherapy improves when patients choose the route of administration: Subcutaneous or sublingualAllergologia et Immunopathologia, 2015
- Neubewertung des Risikos von Test- und TherapieallergenenBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2001
- Comparison of Intradermal and Subcutaneous Injections in Lymphatic MappingJournal of Surgical Research, 2001
- Systemic reactions from allergen immunotherapyJournal of Allergy and Clinical Immunology, 1992
- Immunotherapy with a standardized Dermatophagoides pteronyssinus extractJournal of Allergy and Clinical Immunology, 1990
- Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoidsJournal of Allergy and Clinical Immunology, 1990
- Immunotherapy with cat- and dog-dander extractsJournal of Allergy and Clinical Immunology, 1989
- Comparisons of alum-precipitated and unprecipitated aqueous ragweed pollen extracts in the treatment of hay feverJournal of Allergy and Clinical Immunology, 1978